News
The investigators reported that treatment with darolutamide reduced the risk of radiological progression or death by 49% in ...
“It is likely that more and more, these newer agents are going to play earlier and more central roles in the early treatment of BCG-unresponsive disease," says Shreyas S. Joshi, MD, MPH. He explained, ...
The Glean Urodynamics System received FDA clearance, offering wireless, catheter-free monitoring for lower urinary tract dysfunction, improving patient comfort and data accuracy. The SureForm 45 ...
TAR-200 monotherapy achieved a 6-month DFS of 85.3% and a 9-month DFS of 81.1% in BCG-unresponsive high-risk NMIBC patients. The trial reported high PFS (95.6%) and OS (98.0%) rates at 9 months, with ...
Kevin C. Zorn, MD, FRCSC, FACS, recaps the AUA 2025 session, “State-of-the-Art Lecture: Preservation of Ejaculatory Function with BPH Treatments." Preservation of ejaculatory function is a top ...
Darolutamide plus ADT in mHSPC patients led to significantly lower PSA responses compared to ADT alone, enhancing clinical outcomes. Ultra-low PSA responses (<0.02 ng/mL) correlated with prolonged ...
Welcome back to Pearls & Perspectives, with Amy Pearlman, MD! In this 2-part episode of Pearls and Perspectives fromthe American Urological Association's (AUA) 2025 Annual Meeting in Las Vegas, NV, ...
In this episode, guideline chair Melissa Kaufman, MD, PhD, FACS, highlights key points from the new AUA GSM guideline and illustrates its impact for clinical ...
Welcome back to Pearls & Perspectives! In this episode of Pearls & Perspectives from Urology Times, Amy Pearlman, MD, interviews Rachel Rubin, MD, a urologist and fellowship-trained sexual medicine ...
Video content above is prompted by the following: Aqua Ablation Therapy Benefits Efficacy: Aqua ablation demonstrates noninferior, equal, or superior results compared with TURP (gold standard).
"The decision for which laser to use in your institution should be left up to the urologist and the hospital system," says Margaret A. Knoedler, MD. Data presented at the 2025 American Urological ...
Welcome back to Pearls & Perspectives, with Amy Pearlman, MD! In this episode of Pearls & Perspectives from Urology Times, host Amy Pearlman, MD, sits down with the legendary Larry Lipshultz, MD, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results